Life Sciences Tools and Services
Company Overview of CyVera Corporation
As of April 8, 2005, CyVera Corporation was acquired by Illumina, Inc. CyVera Corporation commercializes life sciences applications of digitally encoded microparticle (bead) technology. Its technology supports standard oligonucleotide, protein, and antibody attachment chemistries, as well as provides the multiplexing power of microarrays. The company was founded in 2003 and is headquartered in Wallingford, Connecticut.
50 Barnes Park North
Wallingford, CT 06492
Founded in 2003
Key Executives for CyVera Corporation
CyVera Corporation does not have any Key Executives recorded.
Similar Private Companies By Industry
|10X Genomics, Inc.||United States|
|4G Clinical, Inc.||United States|
|AAPharmaSyn LLC||United States|
|Abiant, Inc.||United States|
|aBioBot, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact CyVera Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.